seromycin- cycloserine capsule
parsolex gmp center, inc. - cycloserine (unii: 95ik5ki84z) (cycloserine - unii:95ik5ki84z) - indications and usage seromycin ® is indicated in the treatment of active pulmonary and extrapulmonary tuberculosis (including renal disease) when the causative organisms are susceptible to this drug and when treatment with the primary medications (streptomycin, isoniazid, rifampin, and ethambutol) has proved inadequate. like all antituberculosis drugs, seromycin ® should be administered in conjunction with other effective chemotherapy and not as the sole therapeutic agent. seromycin ® may be effective in the treatment of acute urinary tract infections caused by susceptible strains of gram- positive and gram-negative bacteria. use of seromycin ® in these infections should be considered only when more conventional therapy has failed and when the organism has been demonstrated to be susceptible to the drug. contraindications administration is contraindicated in patients with any of the following: • hypersensitivity to seromycin
cycloserine 250mg capsules
alliance healthcare (distribution) ltd - cycloserine - oral capsule - 250mg
cycloserine 250mg capsules
a a h pharmaceuticals ltd - cycloserine - oral capsule - 250mg
cycloserine capsules
belmedpreparaty rue - cycloserine - capsules - 250mg
cycloserine
macleods pharmaceuticals ltd - cycloserine - capsule; oral - 250mg
cycloserine capsules 250mg
macleods pharmaceuticals limited, india - cycloserine - capsules - 250mg
cycloserine 250mg capsules
imported - cycloserine - oral capsule - 250mg
cycloserine 250 mg 250 mg oral solid ordinary capsules
mylan laboratories limited - cycloserine - oral solid ordinary capsules - 250 mg
cycloserine
mylan laboratories limited [otl] - cycloserine - capsule - 250mg
cycloserine capsules usp hard gelatin capsules 125
macleods pharmaceuticals limited, india - cycloserine - hard gelatin capsules - 125